Menu
Recruiting NCT06604793

Creatine Supplementation in Young Healthy Adults

No phase Interventional Improve Muscle Performance in Young Adults

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Creatine, Placebo.
Who it may be relevant to
Registry conditions: Improve Muscle Performance in Young Adults. Basic parameters: 18 years — 39 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Canada
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Effects of Equal-volume Creatine Supplementation With Different Dosing Strategies on Body Composition and Muscle Performance in Young Healthy Adults

Overview

The purpose is to compare the effects of bolus ingestion (5 grams) vs. intermittent ingestion (2 x 2.5 grams) of creatine supplementation vs. placebo for 21 days on measures of body composition (lean tissue mass-indicator of muscle mass, total body water) and muscle performance (i.e., power, strength, endurance).

Detailed description

Creatine is a naturally occurring compound produced in the liver and brain. Creatine can also be found in food products such as red meat and seafood or through commercially available manufactured creatine products (i.e. creatine supplementation).

Evidence-based research shows that creatine supplementation improves measures of body composition and muscle performance. However, the optimal creatine supplementation protocol to achieve these benefits is unknown.

Interventions

  • Dietary supplement Creatine
    Creatine monohydrate
  • Dietary supplement Placebo
    Maltodextrin

Primary outcome measures

  • Whole-body lean mass (kg) [Time frame: baseline, day 21]
  • Strength [Time frame: baseline, day 21]
  • Endurance [Time frame: baseline, day 21]
  • Hydration [Time frame: baseline, day 21]
  • Power [Time frame: baseline, day 21]
  • Power [Time frame: baseline, day 21]

Eligibility criteria

Inclusion criteria

  • if you are 18-39 years of age
  • if you have not been performing resistance training for at least 4 weeks prior to the start of the study.

Exclusion criteria

  • if you are pregnant or nursing
  • have taken creatine monohydrate within 30 days prior to the start of the study
  • if you have pre-existing allergies to the placebo (corn-starch maltodextrin)

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: Yes

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Triple blind
Primary purpose
Treatment

Study locations

Canada · 1 center
  • University of Regina — Regina

Identifiers

NCT: NCT06604793 · 834

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗